Randy is an excellent adviser - we value his ability to bring his experience working with a wide range of startup companies to ensure we take the best course of action.
Randy Socol represents established and emerging growth companies in the technology, biotechnology, healthcare, and sports and gaming sectors, counseling founders, management and boards, and handling matters ranging from corporate formation and governance, equity and debt financings, mergers and acquisitions and capital markets transactions. In addition, he also represents venture capital and private equity firms, corporate and strategic investors and acquirors that finance and acquire these emerging growth companies.
In addition to providing strategic and corporate counseling, his practice encompasses venture capital financings, mergers and acquisitions, debt financings, public offerings, equity and compensation matters and corporate governance.
Randy is a member of the firm's US Emerging Growth and Venture Capital executive committee and a founding member of the firm's Corporate Venture Leadership Group.
Randy has represented emerging growth companies and venture capital and strategic investors in more than 2000 equity and debt financing transactions. Randy's representation of emerging growth companies, including in connection with financing transactions led by some of the world's leading venture capital and corporate investors, has included the following companies:
AbVitro, Inc.
Aspen Neuroscience, Inc.
aTyr Pharma, Inc.
Aumni, Inc.
Ceregene, Inc.
Cloudbeds
Concert Health, Inc.
Cordial Experience, Inc.
Ecwid, Inc.
EdgeCast Networks, Inc.
Epic Sciences, Inc.
Flock Freight, Inc.
Gr4vy, Inc.
inVia Robotics, Inc.
Iterion Therapeutics, Inc.
Kyriba, Inc.
LLamasoft, Inc.
Locanabio, Inc.
mPulse Mobile, Inc.
OpenPath Security, Inc.
Pairwise Plants, Inc.
Pindrop Security, Inc.
Qwick, Inc.
RetailNext, Inc.
Revenue.io, Inc.
Science 37, Inc.
Seraphina Therapeutics, Inc.
Shape Therapeutics, Inc.
Sidecar Health, Inc.
Snap! Mobile, Inc.
Stylitics, Inc.
TakeLessons.com, Inc.
Truvian Sciences, Inc.
Wildfire Systems, Inc.
Zeakal, Inc.
Randy has also represented venture capital firms and strategic investors in debt and equity financing transactions with emerging growth companies, including:
Counterpart Ventures
Eldridge Industries
Elysian Park Ventures
Emergence Capital Partners
Endeavour Vision
Ericsson Ventures
Finistere Ventures
H.I.G. Capital
Lux Ventures
Magnetar Capital
M12 (the venture arm of Microsoft)
Novartis AG
Qualcomm Ventures
Redmile Group
Sante Ventures
SoftBank Vision Fund I and II
Sorenson Ventures
Thomson Reuters
Upfront Ventures
Randy also regularly represents both acquirors and selling companies in merger and acquisition transactions, including acquirors such as:
QUALCOMM Incorporated
NIKE, Inc.
Breg, Inc.
Cloudbeds
Life Technologies Corporation
RetailNext, Inc.
Randy has also represented numerous companies in sell-side transactions constituting successful liquidation events, including the following:
AbVitro, Inc. in its acquisition by Juno Therapeutics
Ceregene, Inc. in its acquisition by Sangamo BioSciences
Ecwid, Inc. in its acquisition by Lightspeed POS
EdgeCast Networks in its acquisition by Verizon
mPulse Mobile, Inc. in its acquisition by Providence Strategic Growth
Llamasoft in its acquisition by TPG, Eventful, Inc. in its acquisition by CBS
OpenPath Security in its acquisition by Motorola
Stelios Therapeutics in its acquisition by Lexeo Therapeutics
TakeLessons, Inc. in its acquisition by Microsoft Corporation
Education
J.D., University of Michigan 1999
B.A., Northwestern University 1996
History
Awards
Chambers USA
Band 3, Nationwide Startups & Emerging Companies (2023-2024)
Band 3, California Venture Capital (2023-2024)
Band 4, California Corporate/M&A: Venture Capital (2022)
Band 4, Nationwide Startups & Emerging Companies (2020-2022)
Band 2, California: San Diego Corporate/M&A (2021-2024)
